Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
Nov 24, 2023
Document Date
Nov 24, 2023
Form Description
S-3ASR
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.